Your session is about to expire
← Back to Search
Ancillary-correlative (tissue and blood procurement) for Cancer
N/A
Recruiting
Led By James H Doroshow
Research Sponsored by National Cancer Institute (NCI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
This research trial collects and stores tissue and blood samples from patients with cancer. Collecting and storing samples of tissue and blood from patients with cancer to study in the laboratory may help scientists create new and better models to learn about cancer and to test new cancer drugs.
Eligible Conditions
- Cancer
- Solid Tumors
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Procurement of tissue and blood specimens for research purposes
Trial Design
1Treatment groups
Experimental Treatment
Group I: Ancillary-correlative (tissue and blood procurement)Experimental Treatment1 Intervention
Tumor tissue and blood samples are procured during procedures that are required for the patients' clinical management and stored via xenograft (transplant to another species) models or in vitro cell culture for future analysis.
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)Lead Sponsor
13,842 Previous Clinical Trials
40,998,000 Total Patients Enrolled
James H DoroshowPrincipal InvestigatorNational Cancer Institute (NCI)
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger